The search for new non-traditional targets is a high priority in antibiotic design today. Bacterial membrane energetics based on sodium ion circulation offers potential alternative targets. The obtained data have immediate relevance for many different diseases caused by pathogenic bacteria that rely on Na + -NQR activity for growth, including sexually transmitted, pulmonary, oral/gum, and ocular infections.
Despite the increasing incidence of antibiotic resistance today, the number of new antibiotics grows at a distressingly slow rate (Russell 2002) . The essential part of the problem is that the vast majority of antibiotics target the same three general prokaryotic pathways: protein synthesis, DNA replication and bacterial cell wall assembly. The identification of new targets outside of these traditional "over-targeted" pathways is, therefore, critical if the problem of antibiotic resistance is to be solved.
Bacterial energetics represents an attractive alternative target. Although the majority of modern bacteria exploit the transmembrane circulation of protons (H + cycle) in their membrane energetics, a number of species rely on the sodium ion circulation (Na + cycle) rather than the H + cycle (Skulachev 1985) . In these bacteria, primary Na + pumps generate the transmembrane electrochemical gradient of Na + which can serve as a direct source of energy for vital functions including substrate accumulation, motility and ATP synthesis (Skulachev 1985) . Importantly, the Na + cycle is widespread among bacterial pathogens (Hase et al 2001) .
Chlamydiae are a good example of such pathogenic bacteria. All chlamydial genomes encode a complete Na + cycle including the Na + -translocating NADH:ubiquinone oxidoreductase (Na + -NQR)
as a major primary Na + pump (Dibrov et al 2004; Dzioba et al 2003; Hase et al 2001; Reyes-Prieto et al 2014) . The Na + -NQR is the major respiratory Na + pump in aerobic pathogens (Hase et al 2001;
Reyes-Prieto et al 2014). Although not homologous to the respiratory Complex I (Dibrov et al 2004; Dzioba et al 2003; Reyes-Prieto et al 2014; Steuber et al 2014) , it occupies the same position in the electron transport chain, using the oxidation of NADH by ubiquinone to drive translocation of Na + across the membrane. Reduction of quinone by the NQR complex is tightly coupled with Na + translocation (Juarez et al 2009; Steuber et al 2014) and is inhibited by the quinone analogs HQNO and korormicin (Hayashi et al 2002; Nakayama et al 1999; Yoshikawa et al 1997) . The Na + cycle may be D r a f t 4 critical for maintaining bacterial energetics operative during chlamydial infection (Dibrov et al 2004) .
It has been hypothesized that the rapid consumption of ATP and glucose by Chlamydiae at the onset of infection would lead to acidification of the host cytoplasm which will in turn activate Na + /H + exchange in the host cells to remove H + and increase Na + influx simultaneously with the inhibition of Na + export via Na + /K + ATPase (Dibrov et al 2004) . The resulting rise in [Na + ] i in the infected cell would support chlamydial accumulation of amino acids and other substrates by sodium-dependent symporters (Dibrov et al 2004) . Thus, the Na + cycle may be instrumental in the infectious process and, in the framework of this hypothesis, the Na + -NQR is a key element in the energization of nutrient uptake by the invading pathogen.
If the preceding line of reasoning is correct, inhibition of Na + -NQR should arrest bacterial energization and proliferation, and ultimately disrupt the infectious process. Korormicin is a naturally occurring antibiotic and the most specific and potent Na + -NQR inhibitor known (Nakayama et al 1999) . In this work, korormicin and a novel synthetic furanone inhibitor of Na + -NQR were used to test the hypothesis that Na + -NQR is a valid therapeutic target in the infection caused by Chlamydia trachomatis. The objectives of the present study were, therefore, two-fold: (i) to assess Na + -NQR as a novel antibiotic target and (ii) to test the efficacy of a newly synthesized furanone Na + -NQR inhibitor to arrest Chlamydia trachomatis infection. 
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MATERIALS AND METHODS
Materials
Measurements of intracellular pH and sodium in cells. pHrodo TM Green AM and CoroNa
Green Sodium Indicator (both Molecular Probes, Invitrogen) were used to measure intracellular pH (pH i ) and intracellular sodium (Na 
RESULTS
Chlamydial invasion perturbs ion homeostasis of infected cells. C. trachomatis infection of HEK293
cells induced changes in cytoplasmic pH and Na + content. As expected, whereas pH did not change in uninfected cells, infected cells became acidic within 2 hrs (Fig. 1A) . The significant cytoplasmic acidification caused by the metabolic activity of chlamydial reticulate bodies (RBs) was followed by a signficant secondary rise in Na trachomatis at 10-20 µM ( Fig. 2A-D) . The extrapolated MIC50 for korormicin (after the 1 st treatment) was ~18.00 µM (Table 1) . However, korormicin was also cytotoxic to mammalian cells at nM concentrations (Fig. 2E) .
Design of synthetic NQR inhibitor, PEG-2. The toxicity of korormicin encouraged us to redesign the inhibitor to be more suitable as an anti-NQR medicine (Dibrov et al 2016 (Bertsova and Bogachev 2004; Fadeeva et al 2007; 2008; Kostyrko et al 2015) . This allows the measurement of NQR activity directly without confounding factors -the enzyme is functioning in its native membrane and feeding the electrons taken from NADH to the respiratory chain. Vesicles isolated from the NQR-positive Vibrio cholerae strain demonstrated a PEG-2S-sensitive oxidation of dNADH (Fig. 4A) . Removal of functional Na + -NQR by the chromosomal nqrA-F deletion resulted in the inability of membranes isolated from the mutant V. cholerae strain to oxidize dNADH (Fig. 4A ). PEG-2S inhibition exhibited an MIC 50 of 1.76 nM (Fig. 4B ).
PEG-2S disrupts chlamydia-induced changes in ionic homeostasis in cells. In accordance with results
shown in Figure 1 , HEK293 cells infected with C. trachomatis displayed a cytoplasmic acidification followed by an increase in Na + i levels (Fig. 5) . The addition of PEG-2S significantly supressed the chlamydia-induced acidification in a dose-dependent manner (Fig. 5A ). As expected, sodium accumulation was delayed relative to the acidification and it was also sensitive to the low µM PEG-2S concentrations (Fig. 5B) .
Anti-chlamydial effects of PEG-2 and PEG-2S.
A single treatment with racemic PEG-2 had a significant effect on infection of HeLa cells by C. trachomatis (Fig. 6 ). PEG-2 was more effective than korormicin by at least 2 orders of magnitude (Fig. 6A) . As expected, PEG-2S was even more potent as an anti-chlamydial agent than PEG-2 (Table 1) . The MIC50 for PEG-2 and PEG-2S was 10 µM and 0.7 µM , respectively. After two consecutive treatments, the MIC50 2 for PEG-2 was 4 µM versus 0.25 µM for PEG-2S (Table 1) . Chlamydial inclusions formed in the presence of PEG-2 were hollow compared to the control non-treated cells (Fig. 6B) , and significantly smaller (Fig. 6C ).
D r a f t
PEG-2 and PEG2S are non-toxic. PEG-2 up to 20 µM (as well as PEG-2S) had no toxic effects on primary cell cultures (Fig. 6D) . Furthermore, PEG-2 and PEG-2S (1-50 µM) did not affect the growth of NQR-negative species, including benign gastrointestinal bacteria, E. coli, E. faecalis and L. lactis (Fig. 7) and pathogenic C. difficile (data not shown).
DISCUSSION
The results presented here are important from two perspectives. First, they demonstrate that the activity of the Na + -NQR is critical for the growth and proliferation of C. trachomatis and provide an explanation for this. The metabolism of invading C. trachomatis increased cytoplasmic [H + ] in the host cell by 10-fold soon after infection, and subsequently elevated intracellular Na + levels as well. Both observed effects have been predicted theoretically in the earlier work (Dibrov et al 2004) . The acidification of the cytoplasm in Chlamydiae-infected cells was thougt to occur due to the rapid catabolism of glucose provided by the host cell (Dibrov et al, 2004; Iliffe-Lee and McClarty, 1999 (Dibrov et al 2004) .
Measurements of internal Na + and pH in uninfected and infected cells confirmed both these predictions ( Fig.5A and B) . This helps to explain why the membrane energetics of this obligate intracellular parasite relies on the sodium-motive force (SMF). Like other members of the Chlamydia genus, C. trachomatis encodes Na + -dependent symporters for the accumulation of a variety of substrates, including amino acids and dicarboxylates (Dibrov et al 2004) . Therefore, it is concluded that the generation and maintenance of the SMF by the Na + -NQR becomes a prerequisite for the proliferation of C. trachomatis.
confirmed the crucial role of Na + -NQR in bacterial proliferation, this inhibitor cannot be advanced clinically as an anti-chlamydial remedy. Conversely, the data with PEG-2 and PEG-2S support this agent as an effective inhibitor of Na + -NQR. The experiments with sub-bacterial membrane vesicles allowed the measurement of Na + -NQR activity directly when the enzyme was operating in a physiologically relevant background (being placed in its native membrane and supplying electrons taken from NADH to the respiratory chain) but without additional permeability barriers and influences from cytoplasmic metabolism (Bertsova and Bogachev 2004; Fadeeva et al 2007; 2008; Kostyrko et al 2015) .
In this model, PEG-2S exhibited a low MIC 50 of 1.76 nM (Fig. 4B ). PEG-2S was also effective against C. trachomatis at low µM concentrations in infected HeLa cells. It was non-toxic to both mammalian cells ( Fig. 6D ) and non-pathogenic gastrointestinal bacteria (Fig. 7) . Na + -NQR is absent in these cell types and this would, therefore, support the contention that PEG-2S is a highly selective inhibitor of Stephens, R.S., Kalman, S., Lammel, C., Fan, J., Marathe, R., Aravind, L., Mitchell, W., Olinger, L., Tatusov, R.L., Zhao, Q., Koonin, E.V., and Davis, R.W. 1998. Racemic mixture of stereoisomers used in some experiments is reffered to as PEG-2. According to the manufacturer, PEG-2 racemate contained ≤10% of desired enantiomer, PEG-2S. 
